Vanda Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. 

CEO
Mihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees
533
Employees533
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2002
Founded2002
Employees
533
Employees533

VNDA Key Statistics

Market cap
315.92M
Market cap315.92M
Price-Earnings ratio
-1.09
Price-Earnings ratio-1.09
Dividend yield
Dividend yield
Average volume
1.22M
Average volume1.22M
High today
$5.28
High today$5.28
Low today
$4.96
Low today$4.96
Open price
$5.05
Open price$5.05
Volume
947.64K
Volume947.64K
52 Week high
$9.94
52 Week high$9.94
52 Week low
$4.27
52 Week low$4.27

Stock Snapshot

The current Vanda Pharmaceuticals(VNDA) stock price is $5.22, with a market capitalization of 315.92M. The stock trades at a price-to-earnings (P/E) ratio of -1.09.

As of 2026-08-14, Vanda Pharmaceuticals(VNDA) stock has fluctuated between $4.96 and $5.28. The current price stands at $5.22, placing the stock +5.3% above today's low and -1.1% off the high.

Vanda Pharmaceuticals(VNDA) shares are trading with a volume of 947.64K, against a daily average of 1.22M.

In the last year, Vanda Pharmaceuticals(VNDA) shares hit a 52-week high of $9.94 and a 52-week low of $4.27.

In the last year, Vanda Pharmaceuticals(VNDA) shares hit a 52-week high of $9.94 and a 52-week low of $4.27.

VNDA News

Investing.com 4d
H.C. Wainwright cuts Vanda Pharmaceuticals price target to $20 - Investing.com

...

H.C. Wainwright cuts Vanda Pharmaceuticals price target to $20 - Investing.com
Simply Wall St 6d
Vanda Pharmaceuticals Inc. Just Reported Earnings, And Analysts Cut Their Target Price

It's shaping up to be a tough period for Vanda Pharmaceuticals Inc. ( ), which a week ago released some disappointing second-quarter results that could have a n...

Vanda Pharmaceuticals Inc. Just Reported Earnings, And Analysts Cut Their Target Price

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.